Sarcopenia and Frailty in COPD: Mechanisms, Relationship with Malnutrition and Potential Therapeutic Interventions
Nutrients · 2026
DOI: 10.3390/nu18122003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, 2026. Verfasst von Saoussen Naas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Semmelweis University, 1085 Budapest, Hungary. Hauptthemen laut MEDLINE: Sarcopenia, Pulmonary Disease, Chronic Obstructive, Frailty, Malnutrition. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 229 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Mangelernährung, Gerontologische Pflege, COPD
Abstract (Originalsprache)
Background
Sarcopenia and frailty are highly prevalent extrapulmonary manifestations of chronic obstructive pulmonary disease (COPD) and are strongly associated with reduced exercise tolerance, exacerbation risk, hospitalizations, and mortality. Beyond inflammation, oxidative stress, and physical inactivity, emerging evidence highlights nutrition as a major modifiable driver of muscle deterioration in COPD. Nutritional deficits impair anabolic signaling, exacerbate proteolysis, worsen mitochondrial dysfunction, and contribute to frailty progression.
Methods
This narrative review synthesizes evidence from PubMed, Embase, Scopus, and Web of Science up to 2025, integrating mechanistic, metabolic, nutritional, and biomarker-related pathways underlying muscle dysfunction in COPD. Studies examining inflammation, hypoxemia, oxidative stress, hormonal imbalance, nutrition, and emerging biomarkers were included.
Results
COPD-related sarcopenia results from converging inflammatory (TNF-α, IL-6), catabolic (FOXO, UPS), metabolic, and vascular mechanisms, compounded by energy deficiency, protein insufficiency, and micronutrient deficits. Inadequate intake of protein, vitamin D, antioxidants, and omega-3 fatty acids increase anabolic resistance, enhance muscle catabolism, and worsen frailty. Nutritional interventions, particularly high-protein supplementation, leucine-enriched formulas, vitamin D repletion, omega-3 fatty acids, and multimodal nutrition–exercise programs, demonstrate benefits in muscle mass, strength, and physical performance. Biomarkers such as GDF-15, CAF22, and specific microRNAs reflect nutritional status and correlate with muscle health in COPD.
Conclusions
Sarcopenia and frailty in COPD arise from a complex interplay of inflammatory, metabolic, nutritional, and lifestyle-related factors. Integrating nutritional assessment and targeted dietary interventions with exercise and pulmonary rehabilitation is essential to counteract anabolic resistance and improve functional outcomes. Advances in biomarker research may support earlier diagnosis and personalized nutrition-based therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pulmonology, Semmelweis University, 1085 Budapest, Hungary.
- Institute of Preventive Medicine and Public Health, Semmelweis University, 1089 Budapest, Hungary.
ORCID-Profile: Mónika Fekete, Riad Bejta, János Tamás Varga
Zitieren
APA
Naas, S., Fekete, M., Bejta, R., Bakos, R., Szalai, B., & Varga, J. T. (2026). Sarcopenia and Frailty in COPD: Mechanisms, Relationship with Malnutrition and Potential Therapeutic Interventions. Nutrients. https://doi.org/10.3390/nu18122003
Vancouver
Naas S, Fekete M, Bejta R, Bakos R, Szalai B, Varga JT. Sarcopenia and Frailty in COPD: Mechanisms, Relationship with Malnutrition and Potential Therapeutic Interventions. Nutrients. 2026. doi:10.3390/nu18122003
BibTeX
@article{Naas2026,
author = {Naas, Saoussen and Fekete, Mónika and Bejta, Riad and Bakos, Regina and Szalai, Borbála and Varga, János Tamás},
title = {Sarcopenia and Frailty in COPD: Mechanisms, Relationship with Malnutrition and Potential Therapeutic Interventions},
journal = {Nutrients},
year = {2026},
doi = {10.3390/nu18122003}
}
EUVIMED